Global Transmucosal Drug Delivery Devices Supply, Demand and Key Producers, 2024-2030

Global Transmucosal Drug Delivery Devices Supply, Demand and Key Producers, 2024-2030

Page: 101

Published Date: 25 Feb 2024

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Transmucosal Drug Delivery Devices market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Transmucosal drug delivery devices are commonly used to deliver drugs locally through the mucous membrane.

This report studies the global Transmucosal Drug Delivery Devices production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Transmucosal Drug Delivery Devices, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Transmucosal Drug Delivery Devices that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Transmucosal Drug Delivery Devices total production and demand, 2019-2030, (K Units)
Global Transmucosal Drug Delivery Devices total production value, 2019-2030, (USD Million)
Global Transmucosal Drug Delivery Devices production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Transmucosal Drug Delivery Devices consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Transmucosal Drug Delivery Devices domestic production, consumption, key domestic manufacturers and share
Global Transmucosal Drug Delivery Devices production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Transmucosal Drug Delivery Devices production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Transmucosal Drug Delivery Devices production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Transmucosal Drug Delivery Devices market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Allergan, Amphastar Pharmaceuticals Inc, Aquestive Therapeutics Inc, ARS Pharmaceuticals, Combinent BioMedical Systems Inc, Aegis Therapeutics LLC, Bespak Europe Ltd and Callitas Therapeutics Inc, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Transmucosal Drug Delivery Devices market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Transmucosal Drug Delivery Devices Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Transmucosal Drug Delivery Devices Market, Segmentation by Type
Buccal Route
Rectal Route
Nasal Route

Global Transmucosal Drug Delivery Devices Market, Segmentation by Application
Hospital
Residential

Companies Profiled:
Allergan
Amphastar Pharmaceuticals Inc
Aquestive Therapeutics Inc
ARS Pharmaceuticals
Combinent BioMedical Systems Inc
Aegis Therapeutics LLC
Bespak Europe Ltd
Callitas Therapeutics Inc

Key Questions Answered
1. How big is the global Transmucosal Drug Delivery Devices market?
2. What is the demand of the global Transmucosal Drug Delivery Devices market?
3. What is the year over year growth of the global Transmucosal Drug Delivery Devices market?
4. What is the production and production value of the global Transmucosal Drug Delivery Devices market?
5. Who are the key producers in the global Transmucosal Drug Delivery Devices market?
btl

Table of Contents

1 Supply Summary
1.1 Transmucosal Drug Delivery Devices Introduction
1.2 World Transmucosal Drug Delivery Devices Supply & Forecast
1.2.1 World Transmucosal Drug Delivery Devices Production Value (2019 & 2023 & 2030)
1.2.2 World Transmucosal Drug Delivery Devices Production (2019-2030)
1.2.3 World Transmucosal Drug Delivery Devices Pricing Trends (2019-2030)
1.3 World Transmucosal Drug Delivery Devices Production by Region (Based on Production Site)
1.3.1 World Transmucosal Drug Delivery Devices Production Value by Region (2019-2030)
1.3.2 World Transmucosal Drug Delivery Devices Production by Region (2019-2030)
1.3.3 World Transmucosal Drug Delivery Devices Average Price by Region (2019-2030)
1.3.4 North America Transmucosal Drug Delivery Devices Production (2019-2030)
1.3.5 Europe Transmucosal Drug Delivery Devices Production (2019-2030)
1.3.6 Asia-Pacific Transmucosal Drug Delivery Devices Production (2019-2030)
1.3.7 ROW Transmucosal Drug Delivery Devices Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Transmucosal Drug Delivery Devices Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Transmucosal Drug Delivery Devices Major Market Trends

2 Demand Summary
2.1 World Transmucosal Drug Delivery Devices Demand (2019-2030)
2.2 World Transmucosal Drug Delivery Devices Consumption by Region
2.2.1 World Transmucosal Drug Delivery Devices Consumption by Region (2019-2024)
2.2.2 World Transmucosal Drug Delivery Devices Consumption Forecast by Region (2025-2030)
2.3 United States Transmucosal Drug Delivery Devices Consumption (2019-2030)
2.4 China Transmucosal Drug Delivery Devices Consumption (2019-2030)
2.5 Europe Transmucosal Drug Delivery Devices Consumption (2019-2030)
2.6 Japan Transmucosal Drug Delivery Devices Consumption (2019-2030)
2.7 South Korea Transmucosal Drug Delivery Devices Consumption (2019-2030)
2.8 ASEAN Transmucosal Drug Delivery Devices Consumption (2019-2030)
2.9 India Transmucosal Drug Delivery Devices Consumption (2019-2030)

3 World Transmucosal Drug Delivery Devices Manufacturers Competitive Analysis
3.1 World Transmucosal Drug Delivery Devices Production Value by Manufacturer (2019-2024)
3.2 World Transmucosal Drug Delivery Devices Production by Manufacturer (2019-2024)
3.3 World Transmucosal Drug Delivery Devices Average Price by Manufacturer (2019-2024)
3.4 Transmucosal Drug Delivery Devices Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Transmucosal Drug Delivery Devices Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Transmucosal Drug Delivery Devices in 2023
3.5.3 Global Concentration Ratios (CR8) for Transmucosal Drug Delivery Devices in 2023
3.6 Transmucosal Drug Delivery Devices Market: Overall Company Footprint Analysis
3.6.1 Transmucosal Drug Delivery Devices Market: Region Footprint
3.6.2 Transmucosal Drug Delivery Devices Market: Company Product Type Footprint
3.6.3 Transmucosal Drug Delivery Devices Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Transmucosal Drug Delivery Devices Production Value Comparison
4.1.1 United States VS China: Transmucosal Drug Delivery Devices Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Transmucosal Drug Delivery Devices Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Transmucosal Drug Delivery Devices Production Comparison
4.2.1 United States VS China: Transmucosal Drug Delivery Devices Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Transmucosal Drug Delivery Devices Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Transmucosal Drug Delivery Devices Consumption Comparison
4.3.1 United States VS China: Transmucosal Drug Delivery Devices Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Transmucosal Drug Delivery Devices Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Transmucosal Drug Delivery Devices Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Transmucosal Drug Delivery Devices Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Transmucosal Drug Delivery Devices Production Value (2019-2024)
4.4.3 United States Based Manufacturers Transmucosal Drug Delivery Devices Production (2019-2024)
4.5 China Based Transmucosal Drug Delivery Devices Manufacturers and Market Share
4.5.1 China Based Transmucosal Drug Delivery Devices Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Transmucosal Drug Delivery Devices Production Value (2019-2024)
4.5.3 China Based Manufacturers Transmucosal Drug Delivery Devices Production (2019-2024)
4.6 Rest of World Based Transmucosal Drug Delivery Devices Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Transmucosal Drug Delivery Devices Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Transmucosal Drug Delivery Devices Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Transmucosal Drug Delivery Devices Production (2019-2024)

5 Market Analysis by Type
5.1 World Transmucosal Drug Delivery Devices Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Buccal Route
5.2.2 Rectal Route
5.2.3 Nasal Route
5.3 Market Segment by Type
5.3.1 World Transmucosal Drug Delivery Devices Production by Type (2019-2030)
5.3.2 World Transmucosal Drug Delivery Devices Production Value by Type (2019-2030)
5.3.3 World Transmucosal Drug Delivery Devices Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Transmucosal Drug Delivery Devices Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Residential
6.3 Market Segment by Application
6.3.1 World Transmucosal Drug Delivery Devices Production by Application (2019-2030)
6.3.2 World Transmucosal Drug Delivery Devices Production Value by Application (2019-2030)
6.3.3 World Transmucosal Drug Delivery Devices Average Price by Application (2019-2030)

7 Company Profiles
7.1 Allergan
7.1.1 Allergan Details
7.1.2 Allergan Major Business
7.1.3 Allergan Transmucosal Drug Delivery Devices Product and Services
7.1.4 Allergan Transmucosal Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Allergan Recent Developments/Updates
7.1.6 Allergan Competitive Strengths & Weaknesses
7.2 Amphastar Pharmaceuticals Inc
7.2.1 Amphastar Pharmaceuticals Inc Details
7.2.2 Amphastar Pharmaceuticals Inc Major Business
7.2.3 Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Product and Services
7.2.4 Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Amphastar Pharmaceuticals Inc Recent Developments/Updates
7.2.6 Amphastar Pharmaceuticals Inc Competitive Strengths & Weaknesses
7.3 Aquestive Therapeutics Inc
7.3.1 Aquestive Therapeutics Inc Details
7.3.2 Aquestive Therapeutics Inc Major Business
7.3.3 Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Product and Services
7.3.4 Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Aquestive Therapeutics Inc Recent Developments/Updates
7.3.6 Aquestive Therapeutics Inc Competitive Strengths & Weaknesses
7.4 ARS Pharmaceuticals
7.4.1 ARS Pharmaceuticals Details
7.4.2 ARS Pharmaceuticals Major Business
7.4.3 ARS Pharmaceuticals Transmucosal Drug Delivery Devices Product and Services
7.4.4 ARS Pharmaceuticals Transmucosal Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 ARS Pharmaceuticals Recent Developments/Updates
7.4.6 ARS Pharmaceuticals Competitive Strengths & Weaknesses
7.5 Combinent BioMedical Systems Inc
7.5.1 Combinent BioMedical Systems Inc Details
7.5.2 Combinent BioMedical Systems Inc Major Business
7.5.3 Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Product and Services
7.5.4 Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Combinent BioMedical Systems Inc Recent Developments/Updates
7.5.6 Combinent BioMedical Systems Inc Competitive Strengths & Weaknesses
7.6 Aegis Therapeutics LLC
7.6.1 Aegis Therapeutics LLC Details
7.6.2 Aegis Therapeutics LLC Major Business
7.6.3 Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Product and Services
7.6.4 Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Aegis Therapeutics LLC Recent Developments/Updates
7.6.6 Aegis Therapeutics LLC Competitive Strengths & Weaknesses
7.7 Bespak Europe Ltd
7.7.1 Bespak Europe Ltd Details
7.7.2 Bespak Europe Ltd Major Business
7.7.3 Bespak Europe Ltd Transmucosal Drug Delivery Devices Product and Services
7.7.4 Bespak Europe Ltd Transmucosal Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Bespak Europe Ltd Recent Developments/Updates
7.7.6 Bespak Europe Ltd Competitive Strengths & Weaknesses
7.8 Callitas Therapeutics Inc
7.8.1 Callitas Therapeutics Inc Details
7.8.2 Callitas Therapeutics Inc Major Business
7.8.3 Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Product and Services
7.8.4 Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Callitas Therapeutics Inc Recent Developments/Updates
7.8.6 Callitas Therapeutics Inc Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Transmucosal Drug Delivery Devices Industry Chain
8.2 Transmucosal Drug Delivery Devices Upstream Analysis
8.2.1 Transmucosal Drug Delivery Devices Core Raw Materials
8.2.2 Main Manufacturers of Transmucosal Drug Delivery Devices Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Transmucosal Drug Delivery Devices Production Mode
8.6 Transmucosal Drug Delivery Devices Procurement Model
8.7 Transmucosal Drug Delivery Devices Industry Sales Model and Sales Channels
8.7.1 Transmucosal Drug Delivery Devices Sales Model
8.7.2 Transmucosal Drug Delivery Devices Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Transmucosal Drug Delivery Devices Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Transmucosal Drug Delivery Devices Production Value by Region (2019-2024) & (USD Million)
Table 3. World Transmucosal Drug Delivery Devices Production Value by Region (2025-2030) & (USD Million)
Table 4. World Transmucosal Drug Delivery Devices Production Value Market Share by Region (2019-2024)
Table 5. World Transmucosal Drug Delivery Devices Production Value Market Share by Region (2025-2030)
Table 6. World Transmucosal Drug Delivery Devices Production by Region (2019-2024) & (K Units)
Table 7. World Transmucosal Drug Delivery Devices Production by Region (2025-2030) & (K Units)
Table 8. World Transmucosal Drug Delivery Devices Production Market Share by Region (2019-2024)
Table 9. World Transmucosal Drug Delivery Devices Production Market Share by Region (2025-2030)
Table 10. World Transmucosal Drug Delivery Devices Average Price by Region (2019-2024) & (USD/Unit)
Table 11. World Transmucosal Drug Delivery Devices Average Price by Region (2025-2030) & (USD/Unit)
Table 12. Transmucosal Drug Delivery Devices Major Market Trends
Table 13. World Transmucosal Drug Delivery Devices Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Transmucosal Drug Delivery Devices Consumption by Region (2019-2024) & (K Units)
Table 15. World Transmucosal Drug Delivery Devices Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Transmucosal Drug Delivery Devices Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Transmucosal Drug Delivery Devices Producers in 2023
Table 18. World Transmucosal Drug Delivery Devices Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Transmucosal Drug Delivery Devices Producers in 2023
Table 20. World Transmucosal Drug Delivery Devices Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 21. Global Transmucosal Drug Delivery Devices Company Evaluation Quadrant
Table 22. World Transmucosal Drug Delivery Devices Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Transmucosal Drug Delivery Devices Production Site of Key Manufacturer
Table 24. Transmucosal Drug Delivery Devices Market: Company Product Type Footprint
Table 25. Transmucosal Drug Delivery Devices Market: Company Product Application Footprint
Table 26. Transmucosal Drug Delivery Devices Competitive Factors
Table 27. Transmucosal Drug Delivery Devices New Entrant and Capacity Expansion Plans
Table 28. Transmucosal Drug Delivery Devices Mergers & Acquisitions Activity
Table 29. United States VS China Transmucosal Drug Delivery Devices Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Transmucosal Drug Delivery Devices Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Transmucosal Drug Delivery Devices Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Transmucosal Drug Delivery Devices Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Transmucosal Drug Delivery Devices Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Transmucosal Drug Delivery Devices Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Transmucosal Drug Delivery Devices Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Transmucosal Drug Delivery Devices Production Market Share (2019-2024)
Table 37. China Based Transmucosal Drug Delivery Devices Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Transmucosal Drug Delivery Devices Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Transmucosal Drug Delivery Devices Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Transmucosal Drug Delivery Devices Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Transmucosal Drug Delivery Devices Production Market Share (2019-2024)
Table 42. Rest of World Based Transmucosal Drug Delivery Devices Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Transmucosal Drug Delivery Devices Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Transmucosal Drug Delivery Devices Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Transmucosal Drug Delivery Devices Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Transmucosal Drug Delivery Devices Production Market Share (2019-2024)
Table 47. World Transmucosal Drug Delivery Devices Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Transmucosal Drug Delivery Devices Production by Type (2019-2024) & (K Units)
Table 49. World Transmucosal Drug Delivery Devices Production by Type (2025-2030) & (K Units)
Table 50. World Transmucosal Drug Delivery Devices Production Value by Type (2019-2024) & (USD Million)
Table 51. World Transmucosal Drug Delivery Devices Production Value by Type (2025-2030) & (USD Million)
Table 52. World Transmucosal Drug Delivery Devices Average Price by Type (2019-2024) & (USD/Unit)
Table 53. World Transmucosal Drug Delivery Devices Average Price by Type (2025-2030) & (USD/Unit)
Table 54. World Transmucosal Drug Delivery Devices Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Transmucosal Drug Delivery Devices Production by Application (2019-2024) & (K Units)
Table 56. World Transmucosal Drug Delivery Devices Production by Application (2025-2030) & (K Units)
Table 57. World Transmucosal Drug Delivery Devices Production Value by Application (2019-2024) & (USD Million)
Table 58. World Transmucosal Drug Delivery Devices Production Value by Application (2025-2030) & (USD Million)
Table 59. World Transmucosal Drug Delivery Devices Average Price by Application (2019-2024) & (USD/Unit)
Table 60. World Transmucosal Drug Delivery Devices Average Price by Application (2025-2030) & (USD/Unit)
Table 61. Allergan Basic Information, Manufacturing Base and Competitors
Table 62. Allergan Major Business
Table 63. Allergan Transmucosal Drug Delivery Devices Product and Services
Table 64. Allergan Transmucosal Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Allergan Recent Developments/Updates
Table 66. Allergan Competitive Strengths & Weaknesses
Table 67. Amphastar Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 68. Amphastar Pharmaceuticals Inc Major Business
Table 69. Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Product and Services
Table 70. Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Amphastar Pharmaceuticals Inc Recent Developments/Updates
Table 72. Amphastar Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 73. Aquestive Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 74. Aquestive Therapeutics Inc Major Business
Table 75. Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Product and Services
Table 76. Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Aquestive Therapeutics Inc Recent Developments/Updates
Table 78. Aquestive Therapeutics Inc Competitive Strengths & Weaknesses
Table 79. ARS Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. ARS Pharmaceuticals Major Business
Table 81. ARS Pharmaceuticals Transmucosal Drug Delivery Devices Product and Services
Table 82. ARS Pharmaceuticals Transmucosal Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. ARS Pharmaceuticals Recent Developments/Updates
Table 84. ARS Pharmaceuticals Competitive Strengths & Weaknesses
Table 85. Combinent BioMedical Systems Inc Basic Information, Manufacturing Base and Competitors
Table 86. Combinent BioMedical Systems Inc Major Business
Table 87. Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Product and Services
Table 88. Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Combinent BioMedical Systems Inc Recent Developments/Updates
Table 90. Combinent BioMedical Systems Inc Competitive Strengths & Weaknesses
Table 91. Aegis Therapeutics LLC Basic Information, Manufacturing Base and Competitors
Table 92. Aegis Therapeutics LLC Major Business
Table 93. Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Product and Services
Table 94. Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Aegis Therapeutics LLC Recent Developments/Updates
Table 96. Aegis Therapeutics LLC Competitive Strengths & Weaknesses
Table 97. Bespak Europe Ltd Basic Information, Manufacturing Base and Competitors
Table 98. Bespak Europe Ltd Major Business
Table 99. Bespak Europe Ltd Transmucosal Drug Delivery Devices Product and Services
Table 100. Bespak Europe Ltd Transmucosal Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Bespak Europe Ltd Recent Developments/Updates
Table 102. Callitas Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 103. Callitas Therapeutics Inc Major Business
Table 104. Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Product and Services
Table 105. Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 106. Global Key Players of Transmucosal Drug Delivery Devices Upstream (Raw Materials)
Table 107. Transmucosal Drug Delivery Devices Typical Customers
Table 108. Transmucosal Drug Delivery Devices Typical Distributors
List of Figure
Figure 1. Transmucosal Drug Delivery Devices Picture
Figure 2. World Transmucosal Drug Delivery Devices Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Transmucosal Drug Delivery Devices Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Transmucosal Drug Delivery Devices Production (2019-2030) & (K Units)
Figure 5. World Transmucosal Drug Delivery Devices Average Price (2019-2030) & (USD/Unit)
Figure 6. World Transmucosal Drug Delivery Devices Production Value Market Share by Region (2019-2030)
Figure 7. World Transmucosal Drug Delivery Devices Production Market Share by Region (2019-2030)
Figure 8. North America Transmucosal Drug Delivery Devices Production (2019-2030) & (K Units)
Figure 9. Europe Transmucosal Drug Delivery Devices Production (2019-2030) & (K Units)
Figure 10. Asia-Pacific Transmucosal Drug Delivery Devices Production (2019-2030) & (K Units)
Figure 11. ROW Transmucosal Drug Delivery Devices Production (2019-2030) & (K Units)
Figure 12. Transmucosal Drug Delivery Devices Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Transmucosal Drug Delivery Devices Consumption (2019-2030) & (K Units)
Figure 15. World Transmucosal Drug Delivery Devices Consumption Market Share by Region (2019-2030)
Figure 16. United States Transmucosal Drug Delivery Devices Consumption (2019-2030) & (K Units)
Figure 17. China Transmucosal Drug Delivery Devices Consumption (2019-2030) & (K Units)
Figure 18. Europe Transmucosal Drug Delivery Devices Consumption (2019-2030) & (K Units)
Figure 19. Japan Transmucosal Drug Delivery Devices Consumption (2019-2030) & (K Units)
Figure 20. South Korea Transmucosal Drug Delivery Devices Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Transmucosal Drug Delivery Devices Consumption (2019-2030) & (K Units)
Figure 22. India Transmucosal Drug Delivery Devices Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Transmucosal Drug Delivery Devices by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Transmucosal Drug Delivery Devices Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Transmucosal Drug Delivery Devices Markets in 2023
Figure 26. United States VS China: Transmucosal Drug Delivery Devices Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Transmucosal Drug Delivery Devices Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Transmucosal Drug Delivery Devices Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Transmucosal Drug Delivery Devices Production Market Share 2023
Figure 30. China Based Manufacturers Transmucosal Drug Delivery Devices Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Transmucosal Drug Delivery Devices Production Market Share 2023
Figure 32. World Transmucosal Drug Delivery Devices Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Transmucosal Drug Delivery Devices Production Value Market Share by Type in 2023
Figure 34. Buccal Route
Figure 35. Rectal Route
Figure 36. Nasal Route
Figure 37. World Transmucosal Drug Delivery Devices Production Market Share by Type (2019-2030)
Figure 38. World Transmucosal Drug Delivery Devices Production Value Market Share by Type (2019-2030)
Figure 39. World Transmucosal Drug Delivery Devices Average Price by Type (2019-2030) & (USD/Unit)
Figure 40. World Transmucosal Drug Delivery Devices Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 41. World Transmucosal Drug Delivery Devices Production Value Market Share by Application in 2023
Figure 42. Hospital
Figure 43. Residential
Figure 44. World Transmucosal Drug Delivery Devices Production Market Share by Application (2019-2030)
Figure 45. World Transmucosal Drug Delivery Devices Production Value Market Share by Application (2019-2030)
Figure 46. World Transmucosal Drug Delivery Devices Average Price by Application (2019-2030) & (USD/Unit)
Figure 47. Transmucosal Drug Delivery Devices Industry Chain
Figure 48. Transmucosal Drug Delivery Devices Procurement Model
Figure 49. Transmucosal Drug Delivery Devices Sales Model
Figure 50. Transmucosal Drug Delivery Devices Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Allergan
Amphastar Pharmaceuticals Inc
Aquestive Therapeutics Inc
ARS Pharmaceuticals
Combinent BioMedical Systems Inc
Aegis Therapeutics LLC
Bespak Europe Ltd
Callitas Therapeutics Inc
btl

Related Reports

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Transmucosal Drug Delivery Devices Supply, Demand and Key Producers, 2024-2030

Global Transmucosal Drug Delivery Devices Supply, Demand and Key Producers, 2024-2030

Page: 101

Published Date: 25 Feb 2024

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Transmucosal Drug Delivery Devices market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Transmucosal drug delivery devices are commonly used to deliver drugs locally through the mucous membrane.

This report studies the global Transmucosal Drug Delivery Devices production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Transmucosal Drug Delivery Devices, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Transmucosal Drug Delivery Devices that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Transmucosal Drug Delivery Devices total production and demand, 2019-2030, (K Units)
Global Transmucosal Drug Delivery Devices total production value, 2019-2030, (USD Million)
Global Transmucosal Drug Delivery Devices production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Transmucosal Drug Delivery Devices consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Transmucosal Drug Delivery Devices domestic production, consumption, key domestic manufacturers and share
Global Transmucosal Drug Delivery Devices production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Transmucosal Drug Delivery Devices production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Transmucosal Drug Delivery Devices production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Transmucosal Drug Delivery Devices market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Allergan, Amphastar Pharmaceuticals Inc, Aquestive Therapeutics Inc, ARS Pharmaceuticals, Combinent BioMedical Systems Inc, Aegis Therapeutics LLC, Bespak Europe Ltd and Callitas Therapeutics Inc, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Transmucosal Drug Delivery Devices market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Transmucosal Drug Delivery Devices Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Transmucosal Drug Delivery Devices Market, Segmentation by Type
Buccal Route
Rectal Route
Nasal Route

Global Transmucosal Drug Delivery Devices Market, Segmentation by Application
Hospital
Residential

Companies Profiled:
Allergan
Amphastar Pharmaceuticals Inc
Aquestive Therapeutics Inc
ARS Pharmaceuticals
Combinent BioMedical Systems Inc
Aegis Therapeutics LLC
Bespak Europe Ltd
Callitas Therapeutics Inc

Key Questions Answered
1. How big is the global Transmucosal Drug Delivery Devices market?
2. What is the demand of the global Transmucosal Drug Delivery Devices market?
3. What is the year over year growth of the global Transmucosal Drug Delivery Devices market?
4. What is the production and production value of the global Transmucosal Drug Delivery Devices market?
5. Who are the key producers in the global Transmucosal Drug Delivery Devices market?
btl

Table of Contents

1 Supply Summary
1.1 Transmucosal Drug Delivery Devices Introduction
1.2 World Transmucosal Drug Delivery Devices Supply & Forecast
1.2.1 World Transmucosal Drug Delivery Devices Production Value (2019 & 2023 & 2030)
1.2.2 World Transmucosal Drug Delivery Devices Production (2019-2030)
1.2.3 World Transmucosal Drug Delivery Devices Pricing Trends (2019-2030)
1.3 World Transmucosal Drug Delivery Devices Production by Region (Based on Production Site)
1.3.1 World Transmucosal Drug Delivery Devices Production Value by Region (2019-2030)
1.3.2 World Transmucosal Drug Delivery Devices Production by Region (2019-2030)
1.3.3 World Transmucosal Drug Delivery Devices Average Price by Region (2019-2030)
1.3.4 North America Transmucosal Drug Delivery Devices Production (2019-2030)
1.3.5 Europe Transmucosal Drug Delivery Devices Production (2019-2030)
1.3.6 Asia-Pacific Transmucosal Drug Delivery Devices Production (2019-2030)
1.3.7 ROW Transmucosal Drug Delivery Devices Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Transmucosal Drug Delivery Devices Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Transmucosal Drug Delivery Devices Major Market Trends

2 Demand Summary
2.1 World Transmucosal Drug Delivery Devices Demand (2019-2030)
2.2 World Transmucosal Drug Delivery Devices Consumption by Region
2.2.1 World Transmucosal Drug Delivery Devices Consumption by Region (2019-2024)
2.2.2 World Transmucosal Drug Delivery Devices Consumption Forecast by Region (2025-2030)
2.3 United States Transmucosal Drug Delivery Devices Consumption (2019-2030)
2.4 China Transmucosal Drug Delivery Devices Consumption (2019-2030)
2.5 Europe Transmucosal Drug Delivery Devices Consumption (2019-2030)
2.6 Japan Transmucosal Drug Delivery Devices Consumption (2019-2030)
2.7 South Korea Transmucosal Drug Delivery Devices Consumption (2019-2030)
2.8 ASEAN Transmucosal Drug Delivery Devices Consumption (2019-2030)
2.9 India Transmucosal Drug Delivery Devices Consumption (2019-2030)

3 World Transmucosal Drug Delivery Devices Manufacturers Competitive Analysis
3.1 World Transmucosal Drug Delivery Devices Production Value by Manufacturer (2019-2024)
3.2 World Transmucosal Drug Delivery Devices Production by Manufacturer (2019-2024)
3.3 World Transmucosal Drug Delivery Devices Average Price by Manufacturer (2019-2024)
3.4 Transmucosal Drug Delivery Devices Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Transmucosal Drug Delivery Devices Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Transmucosal Drug Delivery Devices in 2023
3.5.3 Global Concentration Ratios (CR8) for Transmucosal Drug Delivery Devices in 2023
3.6 Transmucosal Drug Delivery Devices Market: Overall Company Footprint Analysis
3.6.1 Transmucosal Drug Delivery Devices Market: Region Footprint
3.6.2 Transmucosal Drug Delivery Devices Market: Company Product Type Footprint
3.6.3 Transmucosal Drug Delivery Devices Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Transmucosal Drug Delivery Devices Production Value Comparison
4.1.1 United States VS China: Transmucosal Drug Delivery Devices Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Transmucosal Drug Delivery Devices Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Transmucosal Drug Delivery Devices Production Comparison
4.2.1 United States VS China: Transmucosal Drug Delivery Devices Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Transmucosal Drug Delivery Devices Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Transmucosal Drug Delivery Devices Consumption Comparison
4.3.1 United States VS China: Transmucosal Drug Delivery Devices Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Transmucosal Drug Delivery Devices Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Transmucosal Drug Delivery Devices Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Transmucosal Drug Delivery Devices Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Transmucosal Drug Delivery Devices Production Value (2019-2024)
4.4.3 United States Based Manufacturers Transmucosal Drug Delivery Devices Production (2019-2024)
4.5 China Based Transmucosal Drug Delivery Devices Manufacturers and Market Share
4.5.1 China Based Transmucosal Drug Delivery Devices Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Transmucosal Drug Delivery Devices Production Value (2019-2024)
4.5.3 China Based Manufacturers Transmucosal Drug Delivery Devices Production (2019-2024)
4.6 Rest of World Based Transmucosal Drug Delivery Devices Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Transmucosal Drug Delivery Devices Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Transmucosal Drug Delivery Devices Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Transmucosal Drug Delivery Devices Production (2019-2024)

5 Market Analysis by Type
5.1 World Transmucosal Drug Delivery Devices Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Buccal Route
5.2.2 Rectal Route
5.2.3 Nasal Route
5.3 Market Segment by Type
5.3.1 World Transmucosal Drug Delivery Devices Production by Type (2019-2030)
5.3.2 World Transmucosal Drug Delivery Devices Production Value by Type (2019-2030)
5.3.3 World Transmucosal Drug Delivery Devices Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Transmucosal Drug Delivery Devices Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Residential
6.3 Market Segment by Application
6.3.1 World Transmucosal Drug Delivery Devices Production by Application (2019-2030)
6.3.2 World Transmucosal Drug Delivery Devices Production Value by Application (2019-2030)
6.3.3 World Transmucosal Drug Delivery Devices Average Price by Application (2019-2030)

7 Company Profiles
7.1 Allergan
7.1.1 Allergan Details
7.1.2 Allergan Major Business
7.1.3 Allergan Transmucosal Drug Delivery Devices Product and Services
7.1.4 Allergan Transmucosal Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Allergan Recent Developments/Updates
7.1.6 Allergan Competitive Strengths & Weaknesses
7.2 Amphastar Pharmaceuticals Inc
7.2.1 Amphastar Pharmaceuticals Inc Details
7.2.2 Amphastar Pharmaceuticals Inc Major Business
7.2.3 Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Product and Services
7.2.4 Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Amphastar Pharmaceuticals Inc Recent Developments/Updates
7.2.6 Amphastar Pharmaceuticals Inc Competitive Strengths & Weaknesses
7.3 Aquestive Therapeutics Inc
7.3.1 Aquestive Therapeutics Inc Details
7.3.2 Aquestive Therapeutics Inc Major Business
7.3.3 Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Product and Services
7.3.4 Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Aquestive Therapeutics Inc Recent Developments/Updates
7.3.6 Aquestive Therapeutics Inc Competitive Strengths & Weaknesses
7.4 ARS Pharmaceuticals
7.4.1 ARS Pharmaceuticals Details
7.4.2 ARS Pharmaceuticals Major Business
7.4.3 ARS Pharmaceuticals Transmucosal Drug Delivery Devices Product and Services
7.4.4 ARS Pharmaceuticals Transmucosal Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 ARS Pharmaceuticals Recent Developments/Updates
7.4.6 ARS Pharmaceuticals Competitive Strengths & Weaknesses
7.5 Combinent BioMedical Systems Inc
7.5.1 Combinent BioMedical Systems Inc Details
7.5.2 Combinent BioMedical Systems Inc Major Business
7.5.3 Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Product and Services
7.5.4 Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Combinent BioMedical Systems Inc Recent Developments/Updates
7.5.6 Combinent BioMedical Systems Inc Competitive Strengths & Weaknesses
7.6 Aegis Therapeutics LLC
7.6.1 Aegis Therapeutics LLC Details
7.6.2 Aegis Therapeutics LLC Major Business
7.6.3 Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Product and Services
7.6.4 Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Aegis Therapeutics LLC Recent Developments/Updates
7.6.6 Aegis Therapeutics LLC Competitive Strengths & Weaknesses
7.7 Bespak Europe Ltd
7.7.1 Bespak Europe Ltd Details
7.7.2 Bespak Europe Ltd Major Business
7.7.3 Bespak Europe Ltd Transmucosal Drug Delivery Devices Product and Services
7.7.4 Bespak Europe Ltd Transmucosal Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Bespak Europe Ltd Recent Developments/Updates
7.7.6 Bespak Europe Ltd Competitive Strengths & Weaknesses
7.8 Callitas Therapeutics Inc
7.8.1 Callitas Therapeutics Inc Details
7.8.2 Callitas Therapeutics Inc Major Business
7.8.3 Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Product and Services
7.8.4 Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Callitas Therapeutics Inc Recent Developments/Updates
7.8.6 Callitas Therapeutics Inc Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Transmucosal Drug Delivery Devices Industry Chain
8.2 Transmucosal Drug Delivery Devices Upstream Analysis
8.2.1 Transmucosal Drug Delivery Devices Core Raw Materials
8.2.2 Main Manufacturers of Transmucosal Drug Delivery Devices Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Transmucosal Drug Delivery Devices Production Mode
8.6 Transmucosal Drug Delivery Devices Procurement Model
8.7 Transmucosal Drug Delivery Devices Industry Sales Model and Sales Channels
8.7.1 Transmucosal Drug Delivery Devices Sales Model
8.7.2 Transmucosal Drug Delivery Devices Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Transmucosal Drug Delivery Devices Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Transmucosal Drug Delivery Devices Production Value by Region (2019-2024) & (USD Million)
Table 3. World Transmucosal Drug Delivery Devices Production Value by Region (2025-2030) & (USD Million)
Table 4. World Transmucosal Drug Delivery Devices Production Value Market Share by Region (2019-2024)
Table 5. World Transmucosal Drug Delivery Devices Production Value Market Share by Region (2025-2030)
Table 6. World Transmucosal Drug Delivery Devices Production by Region (2019-2024) & (K Units)
Table 7. World Transmucosal Drug Delivery Devices Production by Region (2025-2030) & (K Units)
Table 8. World Transmucosal Drug Delivery Devices Production Market Share by Region (2019-2024)
Table 9. World Transmucosal Drug Delivery Devices Production Market Share by Region (2025-2030)
Table 10. World Transmucosal Drug Delivery Devices Average Price by Region (2019-2024) & (USD/Unit)
Table 11. World Transmucosal Drug Delivery Devices Average Price by Region (2025-2030) & (USD/Unit)
Table 12. Transmucosal Drug Delivery Devices Major Market Trends
Table 13. World Transmucosal Drug Delivery Devices Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Transmucosal Drug Delivery Devices Consumption by Region (2019-2024) & (K Units)
Table 15. World Transmucosal Drug Delivery Devices Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Transmucosal Drug Delivery Devices Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Transmucosal Drug Delivery Devices Producers in 2023
Table 18. World Transmucosal Drug Delivery Devices Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Transmucosal Drug Delivery Devices Producers in 2023
Table 20. World Transmucosal Drug Delivery Devices Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 21. Global Transmucosal Drug Delivery Devices Company Evaluation Quadrant
Table 22. World Transmucosal Drug Delivery Devices Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Transmucosal Drug Delivery Devices Production Site of Key Manufacturer
Table 24. Transmucosal Drug Delivery Devices Market: Company Product Type Footprint
Table 25. Transmucosal Drug Delivery Devices Market: Company Product Application Footprint
Table 26. Transmucosal Drug Delivery Devices Competitive Factors
Table 27. Transmucosal Drug Delivery Devices New Entrant and Capacity Expansion Plans
Table 28. Transmucosal Drug Delivery Devices Mergers & Acquisitions Activity
Table 29. United States VS China Transmucosal Drug Delivery Devices Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Transmucosal Drug Delivery Devices Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Transmucosal Drug Delivery Devices Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Transmucosal Drug Delivery Devices Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Transmucosal Drug Delivery Devices Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Transmucosal Drug Delivery Devices Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Transmucosal Drug Delivery Devices Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Transmucosal Drug Delivery Devices Production Market Share (2019-2024)
Table 37. China Based Transmucosal Drug Delivery Devices Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Transmucosal Drug Delivery Devices Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Transmucosal Drug Delivery Devices Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Transmucosal Drug Delivery Devices Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Transmucosal Drug Delivery Devices Production Market Share (2019-2024)
Table 42. Rest of World Based Transmucosal Drug Delivery Devices Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Transmucosal Drug Delivery Devices Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Transmucosal Drug Delivery Devices Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Transmucosal Drug Delivery Devices Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Transmucosal Drug Delivery Devices Production Market Share (2019-2024)
Table 47. World Transmucosal Drug Delivery Devices Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Transmucosal Drug Delivery Devices Production by Type (2019-2024) & (K Units)
Table 49. World Transmucosal Drug Delivery Devices Production by Type (2025-2030) & (K Units)
Table 50. World Transmucosal Drug Delivery Devices Production Value by Type (2019-2024) & (USD Million)
Table 51. World Transmucosal Drug Delivery Devices Production Value by Type (2025-2030) & (USD Million)
Table 52. World Transmucosal Drug Delivery Devices Average Price by Type (2019-2024) & (USD/Unit)
Table 53. World Transmucosal Drug Delivery Devices Average Price by Type (2025-2030) & (USD/Unit)
Table 54. World Transmucosal Drug Delivery Devices Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Transmucosal Drug Delivery Devices Production by Application (2019-2024) & (K Units)
Table 56. World Transmucosal Drug Delivery Devices Production by Application (2025-2030) & (K Units)
Table 57. World Transmucosal Drug Delivery Devices Production Value by Application (2019-2024) & (USD Million)
Table 58. World Transmucosal Drug Delivery Devices Production Value by Application (2025-2030) & (USD Million)
Table 59. World Transmucosal Drug Delivery Devices Average Price by Application (2019-2024) & (USD/Unit)
Table 60. World Transmucosal Drug Delivery Devices Average Price by Application (2025-2030) & (USD/Unit)
Table 61. Allergan Basic Information, Manufacturing Base and Competitors
Table 62. Allergan Major Business
Table 63. Allergan Transmucosal Drug Delivery Devices Product and Services
Table 64. Allergan Transmucosal Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Allergan Recent Developments/Updates
Table 66. Allergan Competitive Strengths & Weaknesses
Table 67. Amphastar Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 68. Amphastar Pharmaceuticals Inc Major Business
Table 69. Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Product and Services
Table 70. Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Amphastar Pharmaceuticals Inc Recent Developments/Updates
Table 72. Amphastar Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 73. Aquestive Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 74. Aquestive Therapeutics Inc Major Business
Table 75. Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Product and Services
Table 76. Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Aquestive Therapeutics Inc Recent Developments/Updates
Table 78. Aquestive Therapeutics Inc Competitive Strengths & Weaknesses
Table 79. ARS Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. ARS Pharmaceuticals Major Business
Table 81. ARS Pharmaceuticals Transmucosal Drug Delivery Devices Product and Services
Table 82. ARS Pharmaceuticals Transmucosal Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. ARS Pharmaceuticals Recent Developments/Updates
Table 84. ARS Pharmaceuticals Competitive Strengths & Weaknesses
Table 85. Combinent BioMedical Systems Inc Basic Information, Manufacturing Base and Competitors
Table 86. Combinent BioMedical Systems Inc Major Business
Table 87. Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Product and Services
Table 88. Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Combinent BioMedical Systems Inc Recent Developments/Updates
Table 90. Combinent BioMedical Systems Inc Competitive Strengths & Weaknesses
Table 91. Aegis Therapeutics LLC Basic Information, Manufacturing Base and Competitors
Table 92. Aegis Therapeutics LLC Major Business
Table 93. Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Product and Services
Table 94. Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Aegis Therapeutics LLC Recent Developments/Updates
Table 96. Aegis Therapeutics LLC Competitive Strengths & Weaknesses
Table 97. Bespak Europe Ltd Basic Information, Manufacturing Base and Competitors
Table 98. Bespak Europe Ltd Major Business
Table 99. Bespak Europe Ltd Transmucosal Drug Delivery Devices Product and Services
Table 100. Bespak Europe Ltd Transmucosal Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Bespak Europe Ltd Recent Developments/Updates
Table 102. Callitas Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 103. Callitas Therapeutics Inc Major Business
Table 104. Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Product and Services
Table 105. Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 106. Global Key Players of Transmucosal Drug Delivery Devices Upstream (Raw Materials)
Table 107. Transmucosal Drug Delivery Devices Typical Customers
Table 108. Transmucosal Drug Delivery Devices Typical Distributors
List of Figure
Figure 1. Transmucosal Drug Delivery Devices Picture
Figure 2. World Transmucosal Drug Delivery Devices Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Transmucosal Drug Delivery Devices Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Transmucosal Drug Delivery Devices Production (2019-2030) & (K Units)
Figure 5. World Transmucosal Drug Delivery Devices Average Price (2019-2030) & (USD/Unit)
Figure 6. World Transmucosal Drug Delivery Devices Production Value Market Share by Region (2019-2030)
Figure 7. World Transmucosal Drug Delivery Devices Production Market Share by Region (2019-2030)
Figure 8. North America Transmucosal Drug Delivery Devices Production (2019-2030) & (K Units)
Figure 9. Europe Transmucosal Drug Delivery Devices Production (2019-2030) & (K Units)
Figure 10. Asia-Pacific Transmucosal Drug Delivery Devices Production (2019-2030) & (K Units)
Figure 11. ROW Transmucosal Drug Delivery Devices Production (2019-2030) & (K Units)
Figure 12. Transmucosal Drug Delivery Devices Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Transmucosal Drug Delivery Devices Consumption (2019-2030) & (K Units)
Figure 15. World Transmucosal Drug Delivery Devices Consumption Market Share by Region (2019-2030)
Figure 16. United States Transmucosal Drug Delivery Devices Consumption (2019-2030) & (K Units)
Figure 17. China Transmucosal Drug Delivery Devices Consumption (2019-2030) & (K Units)
Figure 18. Europe Transmucosal Drug Delivery Devices Consumption (2019-2030) & (K Units)
Figure 19. Japan Transmucosal Drug Delivery Devices Consumption (2019-2030) & (K Units)
Figure 20. South Korea Transmucosal Drug Delivery Devices Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Transmucosal Drug Delivery Devices Consumption (2019-2030) & (K Units)
Figure 22. India Transmucosal Drug Delivery Devices Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Transmucosal Drug Delivery Devices by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Transmucosal Drug Delivery Devices Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Transmucosal Drug Delivery Devices Markets in 2023
Figure 26. United States VS China: Transmucosal Drug Delivery Devices Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Transmucosal Drug Delivery Devices Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Transmucosal Drug Delivery Devices Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Transmucosal Drug Delivery Devices Production Market Share 2023
Figure 30. China Based Manufacturers Transmucosal Drug Delivery Devices Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Transmucosal Drug Delivery Devices Production Market Share 2023
Figure 32. World Transmucosal Drug Delivery Devices Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Transmucosal Drug Delivery Devices Production Value Market Share by Type in 2023
Figure 34. Buccal Route
Figure 35. Rectal Route
Figure 36. Nasal Route
Figure 37. World Transmucosal Drug Delivery Devices Production Market Share by Type (2019-2030)
Figure 38. World Transmucosal Drug Delivery Devices Production Value Market Share by Type (2019-2030)
Figure 39. World Transmucosal Drug Delivery Devices Average Price by Type (2019-2030) & (USD/Unit)
Figure 40. World Transmucosal Drug Delivery Devices Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 41. World Transmucosal Drug Delivery Devices Production Value Market Share by Application in 2023
Figure 42. Hospital
Figure 43. Residential
Figure 44. World Transmucosal Drug Delivery Devices Production Market Share by Application (2019-2030)
Figure 45. World Transmucosal Drug Delivery Devices Production Value Market Share by Application (2019-2030)
Figure 46. World Transmucosal Drug Delivery Devices Average Price by Application (2019-2030) & (USD/Unit)
Figure 47. Transmucosal Drug Delivery Devices Industry Chain
Figure 48. Transmucosal Drug Delivery Devices Procurement Model
Figure 49. Transmucosal Drug Delivery Devices Sales Model
Figure 50. Transmucosal Drug Delivery Devices Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Allergan
Amphastar Pharmaceuticals Inc
Aquestive Therapeutics Inc
ARS Pharmaceuticals
Combinent BioMedical Systems Inc
Aegis Therapeutics LLC
Bespak Europe Ltd
Callitas Therapeutics Inc
btl

Related Reports

jiaGou

Add To Cart

gouMai

Buy Now